In 2020, Sara et al. (2020) conducted a study using the nerve growth factor (NGF)/interleukin-6 (IL-6) ratio to evaluate the neuroprotective effect of progesterone on experimental diffuse brain injury. The gene discussed is IL6; the disease is brain injury.